结核与肺部疾病杂志 ›› 2021, Vol. 2 ›› Issue (4): 355-360.doi: 10.19983/j.issn.2096-8493.20210133

• 论著 • 上一篇    下一篇

联合检测凝血筛查指标及D-二聚体对新型冠状病毒肺炎患者临床分型的诊断价值

吴迪, 范欣欣, 沈建山, 林友飞, 陈晓红, 黄明翔, 陈力舟()   

  1. 350008 福建省福州肺科医院
  • 收稿日期:2021-10-21 出版日期:2021-12-30 发布日期:2022-01-06
  • 通信作者: 陈力舟 E-mail:fkyyclz@163.com
  • 基金资助:
    福建省科技计划项目(2020Y0007);福州市科技计划项目(2020-XG-024)

Diagnostic value of combined detection of coagulation screening indicators and D-dimer in clinical classification of COVID-19

WU Di, FAN Xin-xin, SHEN Jian-shan, LIN You-fei, CHEN Xiao-hong, HUANG Ming-xiang, CHEN Li-zhou()   

  1. Fuzhou Pulmonary Hospital of Fujian Province, Fuzhou 350008, China
  • Received:2021-10-21 Online:2021-12-30 Published:2022-01-06
  • Contact: CHEN Li-zhou E-mail:fkyyclz@163.com

摘要:

目的 探讨凝血筛查指标和D-二聚体检测结果对新型冠状病毒肺炎患者临床分型的诊断价值。 方法 回顾性收集2020年1月23日至2月26日福建省福州肺科医院确诊为新型冠状病毒肺炎的72例患者的临床资料。于住院时、住院期间及疾病出现进展时,检查患者凝血筛查指标及D-二聚体水平,排除凝血筛查指标及D-二聚体标本为非同时检测的标本,或检测项目不全的标本,最终共获得147份检验结果。再根据采血当天,患者所处的不同临床分型进一步分组:轻型和普通型作为轻症组(72份),重型和危重型作为重症组(75份)。凝血筛查指标包括活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、凝血酶原时间(PT)和血浆纤维蛋白原(Fib)。应用受试者工作特征曲线(ROC)分析探讨凝血筛查指标及D-二聚体水平与患者疾病严重程度的关系,以及对患者临床分型的诊断价值。 结果 重症组D-二聚体及凝血筛查指标中的TT、PT、Fib水平[0.99(0.67,1.63)mg/L、13.05(12.41,13.70)s、12.40(11.70,13.20)s、3.99(3.23,4.75)g/L]均明显高于轻症组[0.04(0.02,0.16)mg/L、12.58(11.93,13.59)s、11.65(11.20,12.20)s、3.36(2.76,3.91)g/L],差异均有统计学意义(Z=-8.780,P<0.001;Z=-2.450,P=0.014;Z=-4.500,P<0.001;Z=-3.600,P<0.001),而APTT水平[27.20(24.80,34.00)s和28.25(25.50,30.55)s]两组间差异无统计学意义(Z=0.060,P=0.951)。绘制ROC曲线进行分析,D-二聚体曲线下面积为0.917(95%CI:0.869~0.964),分别高于TT、PT、Fib的曲线下面积[0.617(95%CI:0.526~0.709)、0.715(95%CI:0.623~0.799)和0.672(95%CI:0.585~0.759)];当约登指数取最大值(0.756)时,D-二聚体的临界值为0.364mg/L,诊断重症组的敏感度为86.7%,特异度为88.9%。 结论 外周血D-二聚体检查指标对新型冠状病毒肺炎疾病分型具有较高的诊断价值,可以作为辅助临床诊疗的一项指标。

关键词: 冠状病毒感染, D-二聚体, 凝血筛查指标, 临床分型, 诊断

Abstract:

Objective To explore the diagnostic value of coagulation screening indicators and D-dimer test results in clinical classification of COVID-19. Methods Clinical data of 72 COVID-19 patients diagnosed in Fuzhou Pulmonary Hospital, Fujian from January 23, 2020 to February 26, 2020 were collected and retrospectively studied. The blood coagulation screening index and D-dimer level of patients were tested on and during hospitalization, and progression. The blood coagulation screening index and D-dimer samples were excluded if not simultaneously tested or the test items not incomplete. Finally, a total of 147 results were obtained. According to different clinical classification on the day of blood collection, the patients were divided into mild group (mild and common types, n=72) and severe group (severe and imminent types, n=75). The coagulation screening indicators include activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT) and plasma fibrinogen (Fib). Receiver operating curve (ROC) was used to analysis the relationship between coagulation screening indicators and D-dimer levels, and the severity of the disease, as well as the diagnostic value of clinical classification. Results The levels of TT, PT, and Fib in the D-dimer and coagulation screening indexes in the severe group were significantly higher than those in the mild group (0.99 (0.67,1.63) mg/L vs 0.04 (0.02,0.16) mg/L, Z=-8.780, P<0.001; 13.05 (12.41,13.70) s vs 12.58 (11.93,13.59) s, Z=-2.450, P=0.014; 12.40 (11.70,13.20) s vs 11.65 (11.20,12.20) s, Z=-4.500, P<0.001; 3.99 (3.23,4.75) g/L vs 3.36 (2.76,3.91) g/L, Z=-3.600, P<0.001), while the difference of APTT was not statistically significant (27.20 (24.80,34.00) s vs 28.25 (25.50,30.55) s, Z=0.060, P=0.951). ROC curve showed that the area under the curve of D-dimer was 0.917 (95%CI: 0.869-0.964), higher than those under TT, PT and Fib (0.617 (95%CI: 0.526-0.709), 0.715 (95%CI: 0.623-0.799) and 0.672 (95%CI: 0.585-0.759), respectively). When the Youden index was the maximum (0.756), the critical value of D-dimer was 0.364 mg/L, the sensitivity and specificity of diagnosis in severe group were 86.7% and 88.9%. Conclusion D-dimer index in peripheral blood had high diagnostic value for classification of COVID-19, and could be used as an indicator of clinical diagnosis and treatment.

Key words: Coronavirus infections, D-dimer, Coagulation screening index, Clinical classification, Diagnosis